Save up to 90% on Sotatercept-Csrk with Coupons, Discount Cards & Patient Assistance Programs

Sotatercept-Csrk is available as a 45 mg or 60 mg single-dose vial.

Sotatercept-Csrk is an FDA-approved medication used to treat adults with pulmonary arterial hypertension (PAH).

Sotatercept-Csrk is an activin signaling inhibitor, which means it blocks the activity of activin in the body. By balancing signals for blood vessel growth, Sotatercept-Csrk prevents the blood vessels in the lungs from getting too thick.

Your dose of Sotatercept-Csrk will be based on your weight in kilograms (kg). The first dose is typically 0.3 mg/kg injected under the skin. Three weeks after that, the typical dose is 0.7 mg/kg injected under the skin every 3 weeks as a maintenance dose.

Sotatercept-Csrk is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Sotatercept-Csrk:

• Headache
• Nose bleeds
• Rash
• Spider veins
• Diarrhea
• Dizziness
• Skin redness

Serious side effects are rare with Sotatercept-Csrk. Contact your healthcare provider immediately if you experience any of the following:

• Signs or symptoms of a blood clot: redness or swelling of the legs, chest pain, difficulty breathing, weakness of the face, sudden confusion
• Severe bleeding: blood in the urine, stool that appears black and sticky, vomit that looks like coffee grounds, bruises that keep getting bigger

There are no major drug interactions listed for this medication. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

Various FDA-approved generic manufacturers

If you can get pregnant, make sure to use effective birth control while you’re taking Sotatercept-Csrk and for at least 4 months after your last dose. This medication can be harmful to an unborn baby.

• Winrevair